$RTON

HealthTalk Live, Inc.

CIK:0001580262|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Revenues	$ 342,197	$ 259,918	$ 1,076,956	$ 809,383
Cost of goods sold	158,947	150,231	486,977	416,347
Gross profit	183,250	109,687	589,979	393,036
Operating expenses
General and administrative	143,525	139,736	539,622	410,324
Advertising and promotion	11,900	4,499	36,685	11,778
Legal and professional	40,980	27,150	83,462	104,491
Depreciation and amortization	1,400	1,400	4,200	4,200
Total operating expenses	197,805	172,785	663,969	530,793
Gain (loss) from operations	(14,555)	(63,098)	(73,990)	(137,757)
Other income and (expense)
Interest expense	(5,441)	(2,845)	(26,883)	(8,720)
Amortization of debt discount	(77,661)	(3,375)	(127,096)	(13,129)
Change in fair value of derivative liability	34,298	0	34,459	51,994
Financing costs	(157,627)	0	(198,412)	(4,250)
Gain on settlement of liabilities	0	0	0	140,297
Total other income (expense)	(206,431)	(6,220)	(317,932)	166,192
Net income (loss) attributable to Right on Brands, Inc.	$ (220,986)	$ (69,318)	$ (391,922)	$ 28,435
Income (loss) per share - basic	$ (0.01)	$ (0.00)	$ (0.02)	$ 0.00
Income (loss) per share - diluted				$ 0.00
Weighted average shares outstanding - basic	25,498,064	23,092,350	25,498,064	23,411,364
Weighted average shares outstanding - diluted				23,549,698

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
OPERATING ACTIVITIES
Net income (loss)	$ (391,922)	$ 28,435
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	4,200	4,200
Amortization of debt discount	127,096	13,129
Financing costs	198,412	4,250
Change in fair value of derivative liability	(34,459)	(51,994)
Gain on settlement of liabilities	0	(140,297)
Changes in operating assets and liabilities:
Accounts receivable	(10,756)	0
Prepaid expenses	0	(6,000)
Inventory	14,933	19,579
Right of use assets and liabilities	1,127	0
Accounts payable	10,366	17,483
Accrued interest payable	26,398	8,720
Accrued expenses	3,256	29,658
NET CASH USED IN OPERATING ACTIVITIES	(51,349)	(72,837)
INVESTING ACTIVITIES
NET CASH USED IN INVESTING ACTIVITIES	0	0
FINANCING ACTIVITIES
Proceeds from notes payable	63,195	202,101
Proceeds from convertible notes payable	105,000	0
Repayment of notes payable	(90,799)	(142,360)
NET CASH PROVIDED BY FINANCING ACTIVITIES	77,396	59,741
NET DECREASE IN CASH	26,047	(13,096)
CASH, BEGINNING OF PERIOD	33,322	28,056
CASH, END OF PERIOD	59,369	14,960
CASH PAID FOR INCOME TAXES	0	0
CASH PAID FOR INTEREST	485	0
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Discount on note payable	14,000	0
Discount on note payable from derivative liability	70,000	0
Discount on convertible note payable from derivative liability	90,971	0
Settlement of derivative liability	82,759	0
Accrued interest settled with note payable	6,805	0
Discount on convertible note payable	5,000	0
Common stock issued for common stock payable	0	36,820
Principal and interest settled	0	33,185
Original issuance discount on notes payable	0	16,991
Recission of shares	$ 0	$ 153,114

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Mar. 31, 2023
Current assets
Cash	$ 59,369	$ 33,322
Accounts receivable	12,554	1,798
Inventory	101,182	116,115
Other current assets	3,221	3,221
Total current assets	176,326	154,456
Non-current assets
Property and equipment, net of depreciation	5,685	9,885
Right of use asset	29,762	42,488
Total non-current assets	35,447	52,373
Total assets	211,773	206,829
Current liabilities
Accounts payable	73,600	63,234
Accounts payable, related party	14,154	14,154
Accrued interest payable	47,829	28,236
Accrued expenses	107,404	104,148
Unearned revenue	12,500	12,500
Lease liability, current portion	26,349	23,388
Notes payable, net of discount	230,554	257,077
Convertible debt, net of discount	258,900	182,051
Derivative liability	242,165	0
Total current liabilities	1,013,455	684,788
Lease liability, non-current	4,540	19,100
Total liabilities	1,017,995	703,888
Stockholders' deficit
Series A Preferred stock; 10,000,000 shares authorized of $.001 par value; 5,000,000 shares issued and outstanding	5,000	5,000
Common stock; par value $0.001; 100,000,000 and 12,000,000,000 shares authorized at December 31, 2023 and March 31, 2023, respectively, 25,498,064 shares issued and outstanding	25,498	25,498
Additional paid-in capital	15,301,443	15,218,684
Common stock payable	15,000	15,000
Accumulated deficit	(16,153,163)	(15,761,241)
Total stockholders' deficit	(806,222)	(497,059)
Total liabilities and stockholders' deficit	$ 211,773	$ 206,829